Here, we report a case of rare GCTSP arising in the neck and we describe the clinicopathologic features and discuss the importance of immunohistochemistry in the differential diagnosis with other giant cell rich tumors.
Figure 1: Ultrasonography of the head and neck shows solid mass.
Immunostainings for CD68, S-100 protein, pancytokeratin, [alpha]-1-antitrypsin (AAT), lysozyme, and vimentin were performed using a sensitive biotin-streptavidin immunoperoxidase technique on 5μ paraffin sections. CD68 immunoreactivity was strong and diffuse in the multinucleated giant cells and focal in the mononuclear cells (Figure 3). Mononuclear and multinucleated tumor cells were also positive for vimentin and alpha-1-antityripsin. Immunohistochemically, lysozyme showed scattered positive spindle cells among negative giant cells. However, both giant cells and spindle cells were negative for S-100, cytokeratin (AE1), and smooth muscle actin. Based on the histopathological and immunohistochemical findings, the final diagnosis of the present case was soft tissue giant cell tumour of low malignant potential.
Giant cell tumors of soft parts have now been reclassified as GCT-ST (i.e., giant cell tumor of low malignant potential) and undifferentiated pleomorphic sarcoma with giant cells (i.e., giant cell malignant fibrous histiocytoma or malignant giant cell tumor of soft parts) in the current (2002) WHO Classification of Tumors of Soft Tissue and Bone[18].
The main differential diagnosis includes giant cell tumor tendon sheath (GCTTS), giant cell reparative granuloma (central giant cell tumors), and giant cell rich malignant fibrous histiocytoma.
GCTTS is an extraarticular counterpart of pigmented villonodular synovitis, that is composed largely of mononuclear histiocytoid cells with scattered osteoclast and Touton type of giant cells, with xanthoma cells. It is different from GCTSP because of its usual localization near joint spaces or bursae, a generally uninodular rather than multinodular growth pattern, and paucity of the giant cells. Metaplastic bone production is not commonly seen in GCTTS. Both tumors are composed of large mononuclear histiocytoid cells and osteoclast type giant cells, but Touton type giant cells are also present in GCTTS. The ratio of giant cells to mononuclear cells is reversed in these two lesions. Unlike GCTTS, large amounts of dense fibrous tissue are absent or scarce in GCTSP[1,2,19,20].
Giant cell reparative granuloma or peripheral giant cell granuloma (PGCG) arises exclusively from the periodontal ligament enclosing the root of a tooth. This unique origin means that such a lesion can only be found within or upon the gingiva or alveolar ridge. Apart from the rather significant difference in location, giant cells in PGCG tend to have fewer nuclei and irregular shapes. They have propensity for clustering around areas of necrosis and haemorrhage, while those in GCTSP are more evenly distributed. There is an increased incidence of osteoid, haemorrhage, and hemosiderin in PGCG compared with GCTSP[1,2,20,21].
GCTSP should be considered different from giant cell rich malignant fibrous histiocytoma (MFH) because the latter is a more aggressive, high grade malignant tumor. Giant cell rich MFH is a multinodular, storiform-pleomorphic MFH with marked cytologic atypia, atypical mitoses, and benign osteoclast-like giant cells. However, GCTSP lack the numerous atypical mitoses and coagulative tumor cell necrosis typical of giant cell rich MFH. The current choice of treatment is to combine aggressive surgical resection and postoperative radiotherapy for these malignant tumors[1,2,20]. Therefore, GCTSP should be separated from giant cell rich MFH, because of their quite different biologic behavior, and far better prognosis.
The differential diagnosis also includes plexiform fibrohistiocytic tumor (PFT). Dermal/subcutaneous location, and identification of bimodal population of cells in these tumors often allows for its distinction. Unlike GCTSP, which shows coarser multinodular pattern, PFT reveals plexiform growth pattern with minute nodules or short facicles of fibroblasts at the dermal subcutaneous interface. In addition, PFT tends to arise in younger patients in a truncal location[1,2,20].
Intravascular fasciitis (IF) may resemble GCTSP because of considerable number of multinucleated giant cells. Typical areas of nodular faciitis characterized by somewhat randomly arrayed bland myofibroblastic cells that are commonly associated with with microcystic change should be searched for the diagnosis of IF. IF involves small or medium-sized veins or arteries in contrast to GCTSP wherein the bulk of the tumor is situated in the dermiş[1,2,20].
Although histologic characteristics of giant cell tumor suggest a mesenchymal origin, the histogenesis is still unknown. The giant cells resemble osteoclasts both microscopically and ultrastructurally. They also have a certain content of hydrolytic enzymes such as acid phosphatase. Recently, some studies have confirmed the osteoclastic nature of giant cells in giant-cell-rich MFH and have shown that osteoclasts are also present in the GCTSP of low-grade malignant potential[22].
The treatment of GCTSP remains controversial because of the small number of reported cases. Radical surgery has been widely accepted as a mode of treatment for GCTSP. However, because of the possibility of local recurrence, clinical follow up with or without postoperative radiotherapy is advised after excision. Although some authors advocate adjuvant radiotherapy as a treatment of GCTSP, many aspects of this mode of treatment have not been clarified[15]. After a multidisciplinary discussion, postoperative radiotherapy was proposed. Our patient was given postoperative radiotherapy to the neck. The affected side of the ipsilateral neck was treated with opposed tangential fields. She received 5000 cGy in 25 fractions delivered over a period 5 weeks.
In patients with clinical follow-up that ranges from 34 to 45 months, GCTSP was associated with a local recurrence rate of 12%, and very rare metastasis and death. No clinicopathologic factors are currently predictive of metastatic behaviour associated with GCTSP[1,6,7]. Two years after surgical and radiotherapy treatment, our case was alive and showed no evidence of recurrence and or metastasis.
In conclusion, GCTSP should be kept in mind in the differential diagnosis of other osteoclast-like giant cell-rich tumors of the neck.
1) Fletcher CDM, Unni KK, Mertens F: Pathology and Genetics of
Tumors of Soft Tissue and Bone. WHO Classification of Tumors.
Lyon, IARC Pres, 2002, 310-312
2) Weiss SW, Goldblum JR (Eds): Enzinger and Weiss’s Soft Tissue
Tumours, 5th ed. Philadelphia: Elsevier; 2008, 398-401
3) Salm R, Sissons HA: Giant cell tumors of soft tissues. J Pathol
1972, 107:27-39 [ Özet ]
4) Guccion JG, Enzinger FM: Malignant giant cell tumor of soft
parts. An analysis of 32 cases. Cancer 1972, 29:1518-1529 [ Özet ]
5) Folpe AL, Morris RJ, Weiss SW: Soft tissue giant cell tumor of
low malignant potential: A proposal for the reclassification
of malignant giant cell tumor of soft parts. Mod Pathol 1999,
12:894-902 [ Özet ]
6) O’Connell JX, Wehrli BM, Nielsen GP, Rosenberg AE: Giant cell
tumors of soft tissue: A clinicopathologic study of 18 benign and
malignant tumors. Am J Surg Pathol 2000, 24:386-395 [ Özet ]
7) Oliveira AM, Dei Tos AP, Fletcher CD, Nascimento AG: Primary
giant cell tumor of soft tissues: A study of 22 cases. Am J Surg
Pathol 2000, 24:248-256 [ Özet ]
8) Rodriguez-Peralto JL, Lopez-Barea F, Fernandez-Delgado J:
Primary giant cell tumor of soft tissues similar to bone giant cell
tumor: A case report and literature review. Pathol Int 2001, 51:
60-63 [ Özet ]
9) May SA, Deavers MT, Resetkova E, Johnson D, Albarracin CT:
Giant cell tumor of soft tissue arising in breast. Ann Diagn Pathol
2007, 11:345-349 [ Özet ]
10) Boneschi V, Parafioriti A, Armiraglio E, Gaiani F, Brambilla L:
Primary giant cell tumor of soft tissue of the groin - a case of 46
years duration. J Cutan Pathol 2009, 36 (Suppl 1):20-24 [ Özet ]
11) Tuluc M, Zhang X, Inniss S: Giant cell tumor of the nasal cavity:
Case report. Eur Arch Otorhinolaryngol 2007, 264:205-208 [ Özet ]
12) Ryś J, Kruczak A, Marczyk E, Skotnicki P, Moskal J, Ambicka A,
Harazin-Lechowska A, Wasilewska A, Vogelgesang M, Dyczek
S: Primary soft tissue giant cell tumour of the neck. Cytological
and histological characteristics of the tumour and differential
diagnosis. Pol J Pathol 2009, 60:98-104, quiz 105 [ Özet ]
13) Pepper T, Falla L, Brennan PA: Soft tissue giant cell tumour of
low malignant potential arising in the masseter-a rare entity in
the head and neck. Br J Oral Maxillofac Surg 2010, 48:149-151
14) Wieneke JA, Gannon FH, Heffner DK, Thompson LD: Giant cell
tumor of the larynx: A clinicopathologic series of eight cases and
a review of the literature. Mod Pathol 2001, 14:1209-1215 [ Özet ]
15) Werner JA, Harms D, Beigel A: Giant cell tumor of the larynx:
Case report and review of the literature. Head Neck 1997, 19:
153-157
16) Hoang MP, Rogers BB, Albores-Saavedra J: Giant cell tumor of
the skin: A morphologic and immunohistochemical study of five
cases. Ann Diagn Pathol 2002, 6:288-293
17) Trabelsi A, Hammedi F, Slama A, Abdelkarim SB, Beïzig N,
Khochtali H, Taher YM, Korbi S: Giant cell tumor of soft tissue
of neck: A case report. North Am J Med Sci 2009, 1:319-320 [ Özet ]
18) Nascimento AG: Giant Cell Tumor of Soft Tissue. In: Fletcher
CDM, Unni KK, Mertens F (eds): World Health Organization
Classification of Tumours. Pathology and Genetics of Tumours
of Soft Tissue and Bone. IARC Press, Lyon, 2002, 118-119
19) Beal M, Mayerson J, Wakely PE Jr: Fine-needle aspiration
cytology of giant cell tumor of soft tissue (soft tissue giant cell
tumor of low malignant potential). Ann Diagn Pathol 2003;
7:365-369 [ Özet ]
20) Guillou L, Folpe AL: Fibroblastic and Fibrohistiocytic Tumors
of Soft Tissue. In: Folpe AL, Inwards CY, (eds): Bone and Soft
Tissue Pathology - A Volume in the Foundations in Diagnostic
Pathology Series. 1st ed. Philadelphia, Elsevier Inc, 2010
21) Katsikeris N, Kakarantza-Angelopoulou E, Angelopoulos AP:
Peripheral giant cell granuloma: Clinicopathologic study of 224
new cases and review of 959 reported cases. Int J Oral Maxillofac
Surg 1988, 17: 94-99 [ Özet ]
22) Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N:
Phenotypic and molecular studies of giant-cell tumors of bone
and soft tissue. Hum Pathol 2005, 36: 945-954 [ Özet ]